Instrumental Wealth’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$544K Buy
453
+75
+20% +$76.6K 0.28% 40
2026
Q1
$347K Sell
378
-21
-5% -$21.3K 0.21% 42
2025
Q4
$408K Buy
399
+62
+18% +$59.3K 0.24% 39
2025
Q3
$284K Sell
337
-9
-3% -$6.7K 0.2% 52
2025
Q2
$267K Buy
346
+25
+8% +$19.4K 0.21% 47
2025
Q1
$284K Buy
321
+34
+12% +$28.3K 0.26% 43
2024
Q4
$251K Hold
287
0.24% 42
2024
Q3
$266K Sell
287
-49
-15% -$44.1K 0.26% 36
2024
Q2
$276K Sell
336
-3
-0.9% -$2.4K 0.29% 35
2024
Q1
$274K Buy
+339
New +$241K 0.12% 34

Other funds holding LLY

Instrumental Wealth's LLY Position: Q2 2026 in Review

Instrumental Wealth increased its Eli Lilly (LLY) stake by 20% in Q2 2026, buying an estimated $76.6K and bringing the position to 453 shares worth $544K. The position accounts for 0.28% of the portfolio, ranked #40.

Instrumental Wealth first reported a position in LLY in Q1 2024 and has held it in 10 quarters since. 841 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Instrumental Wealth held 453 shares of Eli Lilly worth $544K as of Q2 2026.
  • Instrumental Wealth bought 75 Eli Lilly shares in Q2 2026, an estimated $76.6K.
  • Eli Lilly made up 0.28% of Instrumental Wealth's portfolio in Q2 2026, its #40 holding.
  • Instrumental Wealth first reported a position in Eli Lilly in Q1 2024 and has held it in 10 quarters since.
  • 841 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Instrumental Wealth's 13F filing for Q2 2026, filed 16 Jul 2026.